Phosphorus

How we're building the world's biggest optical telescope to crack some of the greatest puzzles in science

Retrieved on: 
Wednesday, November 8, 2023
Dark, Planet, Pink, Water, Temperature, Object (computer science), Life, Pressure, Extremely Large Telescope, Walking, Moon, James Webb Space Telescope, Carbon, Harmoni, Telescope, Light, Methane, ELT, Galaxy, Dark side, Oxygen, Orbit, Eye, Gas, Chemistry, Movement, Tick, Astronomy, Solar System, Heriot-Watt University, Starlight, Phosphorus, Goldilocks and the Three Bears

Now a large group of astronomers from all over the world is building the biggest optical telescope ever – the Extremely Large Telescope (ELT) — in Chile.

Key Points: 
  • Now a large group of astronomers from all over the world is building the biggest optical telescope ever – the Extremely Large Telescope (ELT) — in Chile.
  • Once construction is completed in 2028, it could provide answers that transform our knowledge of the universe.
  • With its 39-metre diameter primary mirror, the ELT will contain the largest, most perfect reflecting surface ever made.

Alien life

  • The ELT may also offer an answer to the most fundamental question of all: are we alone in the universe?
  • Occupying the so-called Goldilocks zone, these Earth-like planets will orbit their star at just the right distance for water to neither boil nor freeze – providing the conditions for life to exist.
  • To learn if life is likely to exist on an exoplanet, astronomers must complement imaging with spectroscopy.
  • While images reveal shape, size and structure, spectra tell us about the speed, temperature and even the chemistry of astronomical objects.
  • For giant exoplanets, the Harmoni instrument will analyse light that has travelled through their atmospheres, looking for the signs of water, oxygen, methane, carbon dioxide and other gases that indicate the existence of life.
  • From previous satellite missions, astronomers already have a good idea of where to look in the sky for exoplanets.
  • Tiny shifts in the positions of these features — around 1/10,000th of a pixel on the Andes sensor — may, over months and years, reveal the periodic wobbles.
  • This scale will remain constant over decades, mitigating the measurement errors that occur from environmental changes in temperature and pressure.
  • It is only by looking far outside our Solar System that we can gain a perspective beyond the here and now.


Derryck Reid receives funding from the UK Science and Technology Facilities Council (STFC).

Phosphorus Partners with Check Point to Provide Unprecedented xIoT Visibility, Management, and Remediation

Retrieved on: 
Wednesday, November 8, 2023
Internet of things, SCADA, Triage, SOC, Policy, OT, Check Point, IAD, Industrial internet of things, Incident, ICS, Organization, Destroy Lonely, CPS, Partnership, Critical, Cyber-physical system, IoMT, Intelligence, Risk management, Phosphorus

The new partnership provides the industry’s most advanced asset-centric xIoT visibility at the network level.

Key Points: 
  • The new partnership provides the industry’s most advanced asset-centric xIoT visibility at the network level.
  • We look forward to working with Phosphorus on this new partnership that provides the industry's most advanced asset-centric xIoT visibility at the network level."
  • Through the Phosphorus integration, organizations can extend their existing Check Point investments with in-depth context on their xIoT device footprints.
  • The integration of Phosphorus’s innovative asset-centric xIoT security capabilities with Check Point’s renowned network-centric security creates a powerful new unified approach to xIoT asset visibility, management and security.

HEALTH&BEAUTY, H&B Multi Vitamin Filter Shower Head set launched in Hong Kong

Retrieved on: 
Tuesday, November 7, 2023
Child, Water, Microplastics, Head, Skin, Chlorine, White, ParknShop, Capsule, Taste, HEALTH, Hygiene, Korea, Nutrient, Phosphorus, Perfume

JEONJU-SI, Republic of Korea, Nov. 07, 2023 (GLOBE NEWSWIRE) -- HEALTH&BEAUTY has launched its high-quality H&B Multi Vitamin Filter Shower Head set (多功能維他命過濾式花灑頭) in Hong Kong. This set consists of Multi Vitamin Filter Shower Head, which is an item that ensures cleaner and safer access to tap water.

Key Points: 
  • JEONJU-SI, Republic of Korea, Nov. 07, 2023 (GLOBE NEWSWIRE) -- HEALTH&BEAUTY has launched its high-quality H&B Multi Vitamin Filter Shower Head set (多功能維他命過濾式花灑頭) in Hong Kong.
  • This set consists of Multi Vitamin Filter Shower Head, which is an item that ensures cleaner and safer access to tap water.
  • What differentiates H&B Multi Vitamin Filter Shower Head from other shower heads is the presence of a secondary ring-filter layer.
  • - Multi Vitamin Filter Shower Head Set (White, Black)

Mapp Launches New AI Assistant

Retrieved on: 
Tuesday, November 7, 2023
Cloud, SMS, Churn, Customer experience, ChatGPT, Root cause analysis, ROI, Marketing, Anomaly, AI, Translation, SAN, Sales, Customer service, Phosphorus, MAPP

SAN DIEGO, Nov. 7, 2023 /PRNewswire/ -- Mapp, the leading international provider of insight-led customer experience solutions, has today announced the latest addition to the Mapp Cloud – Mapp AI Assistant, designed to enhance and automate marketers' cross-channel campaigns.

Key Points: 
  • SAN DIEGO, Nov. 7, 2023 /PRNewswire/ -- Mapp , the leading international provider of insight-led customer experience solutions, has today announced the latest addition to the Mapp Cloud – Mapp AI Assistant, designed to enhance and automate marketers' cross-channel campaigns.
  • With Mapp AI Assistant, we're introducing our customers to AI tools that support more informed decisions and contribute to the success of their marketing efforts.
  • Eric Lubow, CPTO of Mapp adds: "The Mapp AI Assistant marks a new milestone in the evolution of AI integration within our platform, reflecting our vision for more intelligent and streamlined marketing.
  • To discover more about how Mapp AI Assistant can transform your marketing, and to find out about more updates and improvements from Mapp visit: Mapp AI Assistant - Mapp

Planet Earth III: how cookie cutter nature programming could fail to educate and inform audiences

Retrieved on: 
Tuesday, November 7, 2023
Universe, Survival, Courtship, Time, Gorilla, Human, Climate, Face, Narration, BBC, Atmosphere, Budget, Breeding, Ecosystem, Love, Animal, Eye, Netflix, Noise, Amazon, Climate change, BBC Studios Natural History Unit, Beauty, Nature, Television, Film industry, Entertainment, Phosphorus

Perhaps nothing embodies the BBC’s values of inform, educate and entertain more than its nature documentaries.

Key Points: 
  • Perhaps nothing embodies the BBC’s values of inform, educate and entertain more than its nature documentaries.
  • In terms of its story, Planet Earth III warns of environmental catastrophe more than any similar BBC show before it.
  • But with them all creating similar programmes, what effect does that have on their ability to inform, educate or entertain?

Comforting catastrophe

  • Copyright laws can protect a show’s characters or plot, but not a visual, musical or storytelling style.
  • Netflix has expanded their scope with Our Planet, Our Planet II and Our Universe (2022).
  • These stories all follow a single format, comforting in its familiarity but should anything that seeks to educate about climate catastrophe be comforting?
  • What do we lose when environmental stories are all told through the same lens and speak with the same voice?

Tackling climate change head on

  • The first season did, however, offer one distinct competitive edge: a clear focus on environmental issues, which the BBC’s had been sorely lacking.
  • The BBC’s nature documentaries have come under considerable criticism over the years for not addressing the climate and ecological crisis.
  • Historically, the BBC had chosen to stay neutral on the debate about human-caused global heating and this decision affected the Planet shows.
  • This one change, while great and urgently needed, has been quickly folded into the planet format and is a feature of all subsequent nature shows.


Looking for something good? Cut through the noise with a carefully curated selection of the latest releases, live events and exhibitions, straight to your inbox every fortnight, on Fridays. Sign up here.
Leora Hadas does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Ardelyx Shares Positive Data from Studies of XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor, at ASN Kidney Week 2023

Retrieved on: 
Friday, November 3, 2023
Spotlight, Education, Incidence, Food, Diarrhea, Sevelamer, Doctor of Philosophy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Society, American Society of Nephrology, SAE, Chronic kidney disease, Quality of life, Dialysis, ASN, Kidney disease, Peritoneal dialysis, CKD, Safety, Kidney, Hospital, Pennsylvania Convention Center, Cohort, Memory, Pharmaceutical industry, Phosphorus, Patient, MD, Hyperphosphatemia, Nephrology

Ardelyx’s presence at Kidney Week 2023 will honor the memory of Derek Forfang, Chair of the Ardelyx Patient Advisory Council and a passionate advocate for patients with kidney disease.

Key Points: 
  • Ardelyx’s presence at Kidney Week 2023 will honor the memory of Derek Forfang, Chair of the Ardelyx Patient Advisory Council and a passionate advocate for patients with kidney disease.
  • XPHOZAH offers a different mechanism of action that blocks phosphate absorption at the primary pathway and is administered as a single tablet taken twice daily.
  • Additionally, Ardelyx is hosting an XPHOZAH Exhibitor Spotlight at ASN Kidney Week 2003.
  • Director of Home and Peritoneal Dialysis Programs, Boise Kidney & Hypertension Institute, and by David Spiegel, MD, Vice President of Nephrology at Ardelyx.

MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023

Retrieved on: 
Friday, November 3, 2023
Neoplasm, Nivolumab, MSI, Cell, Testicular cancer, Memorial Sloan Kettering Cancer Center, Neurotoxicity, SITC, Immunotherapy, Cytokine release syndrome, Mink, Annual general meeting, Lung cancer, Society, Cancer, Therapy, Patient, HLA, Failure, Phosphorus, Vaccine, Pharmaceutical industry, Medical imaging

AgenT-797 showed long-term persistence and induced a potent anti-tumor response, including increased infiltration of cytotoxic immune cells into tumors.

Key Points: 
  • AgenT-797 showed long-term persistence and induced a potent anti-tumor response, including increased infiltration of cytotoxic immune cells into tumors.
  • AgenT-797 was detected in the periphery for up to 6 months and persistence was independent of HLA matching.
  • An increased level of immune cell tumor infiltration and neoantigen driven expansion of anti-tumor cytotoxic T cells was observed following administration.
  • Expansion of clinical programs are underway in additional solid tumor settings, including relapsed/refractory gastric cancer.

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023

Retrieved on: 
Thursday, November 2, 2023
Uric acid, Session, University of Colorado Colorado Springs, ADPKD, Xanthine oxidase, Polycystic kidney disease, Effect, Cytokine, Research, Society, American Society of Nephrology, Acute kidney injury, PKD, ASN, Hyperuricemia, Kidney disease, University, Diet, Nephrology, Therapy, Patient, Oxipurinol, Pharmaceutical industry, Phosphorus, Prognosis

CALGARY, Alberta, Nov. 02, 2023 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce the presentation of new research findings at the American Society of Nephrology meeting being held November 3, 2023 in Philadelphia. The abstract entitled "The Effect of Lowering Uric Acid with a Xanthine Oxidase Inhibitor on PKD in Mice” was reviewed by the ASN review panel for scientific merit and novel discoveries. The studies were conducted at the University of Colorado in the independent laboratory of Dr. Charles Edelstein and were sponsored by XORTX. The studies will be presented at Kidney Week during the Session Title: Genetic Diseases: Cystic - Therapeutic Investigations and Prognosis, November 2, 2023.

Key Points: 
  • The studies were conducted at the University of Colorado in the independent laboratory of Dr. Charles Edelstein and were sponsored by XORTX.
  • The studies will be presented at Kidney Week during the Session Title: Genetic Diseases: Cystic - Therapeutic Investigations and Prognosis, November 2, 2023.
  • This poster reports amalgamated results of studies in either rat and mouse models of polycystic kidney disease (“PKD”) challenged with low to moderate circulating uric acid.
  • The effect of increased uric acid on cyst growth – kidney size - and kidney function, as well as inflammatory markers was measured.

New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

Retrieved on: 
Thursday, November 2, 2023
EGFR, Secondary hyperparathyroidism, SHPT, ERC, Health, Glomerular filtration rate, HIV disease progression rates, Society, American Society of Nephrology, Phosphorus, Chronic kidney disease, Dialysis, Parathyroid hormone, ASN, Serum, OPKO Health, CKD, Patient, Calcium, Pharmaceutical industry

MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) presented late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney Week in Philadelphia today.

Key Points: 
  • MIAMI, Nov. 02, 2023 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) presented late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney Week in Philadelphia today.
  • Treatment with RAYALDEE was not associated with clinically meaningful increases in serum calcium or phosphorus.
  • “RAYALDEE is a safe and highly effective treatment for SHPT in patients with stage 3 or 4 CKD.
  • The new data presented today clearly highlight the possibility that raising serum 25-hydroxyvitamin D to a sufficiently high level to achieve consistent iPTH control with RAYALDEE would improve outcomes in CKD patients.”

Rising Health Consciousness and Environmental Sustainability Drive Growth of Global Toothpaste Tablet Market - ResearchAndMarkets.com

Retrieved on: 
Thursday, November 2, 2023
Health, Discount, Variety, Retail, Dental, Supermarket, Water, Colgate-Palmolive, Urbanization, Aspirin, Acquisition, Dental care, Tablet, Growth, Water resources, Saliva, Travel, Oral hygiene, Online shopping, Phosphorus, Dentistry

The global toothpaste tablet market is on the cusp of remarkable growth within the projected timeframe, fueled by the rising health consciousness among consumers worldwide, the rapid urbanization trend, and a growing emphasis on environmental sustainability.

Key Points: 
  • The global toothpaste tablet market is on the cusp of remarkable growth within the projected timeframe, fueled by the rising health consciousness among consumers worldwide, the rapid urbanization trend, and a growing emphasis on environmental sustainability.
  • Recognized for their environmental friendliness and suitability for travel, toothpaste tablets are poised for continuous growth throughout the forecast period.
  • Companies are launching novel offerings to attract customers, stimulating demand and propelling international growth in the toothpaste tablet market.
  • Environmentally conscious consumers are increasingly turning to toothpaste tablets, recognizing the environmental footprint of conventional oral care products, particularly toothpaste.